Cingulate Inc. filed a Form 8-K on November 13, 2026, disclosing an amendment to its at-the-market sales agreement and the release of its financial results for the quarter ended September 30, 2026.
Key Highlights
- ATM Agreement amended: On November 13, 2026, Cingulate entered into Amendment No. 2 to its ATM Sales Agreement to add Maxim Group LLC as a sales agent alongside existing agent A.G.P./Alliance Global Partners.
- Original ATM capacity: The ATM Agreement, first entered on March 24, 2026, allows the company to offer and sell common stock with an aggregate offering price of up to $100,000,000.
- Q3 2026 results released: Cingulate issued a press release on November 13, 2026, announcing financial results for the quarter ended September 30, 2026, along with a regulatory update.
- Common stock details: The shares covered under the ATM Agreement carry a par value of $0.0001 per share.
- Emerging growth company: The filing confirms Cingulate is classified as an emerging growth company under applicable SEC rules.
Cingulate Expands ATM Sales Agent Roster and Discloses Q3 2026 Financials
According to the filing, Cingulate Inc. (NASDAQ:CING) reported two significant developments on November 13, 2026. First, the company amended its existing at-the-market equity offering agreement, originally executed on March 24, 2026, with A.G.P./Alliance Global Partners. The amendment, designated Amendment No. 2, adds Maxim Group LLC as an additional sales agent under the ATM Agreement. The filing states that the amendment was entered into "solely to add Maxim Group LLC as an Agent under the ATM Agreement."
The ATM Agreement permits Cingulate to offer and sell shares of its common stock, par value $0.0001 per share, having an aggregate offering price of up to $100,000,000, from time to time through the designated agents. The full text of the amendment is filed as Exhibit 10.1 to the 8-K. The filing notes that the description of the amendment "is qualified in its entirety by reference to the full text of the Amendment."
Separately, the company disclosed under Item 2.02 that it issued a press release on November 13, 2026, covering financial results for the quarter ended September 30, 2026, and providing a regulatory update. The filing specifies that the press release and related Item 2.02 disclosures are furnished, not filed, for purposes of Section 18 of the Securities Exchange Act of 1934, and are therefore not subject to the liabilities of that section. The 8-K was signed by Jennifer L. Callahan, Chief Financial Officer of Cingulate Inc.
What Was Disclosed
Cingulate Inc. disclosed the addition of Maxim Group LLC as a co-agent under its existing up-to-$100,000,000 ATM equity offering agreement and announced the release of its third-quarter 2026 financial results and a regulatory update via press release.



Please wait processing your request...